dbACP: A Comprehensive Database of Anti-Cancer Peptides

dbacp05099

General Description

Peptide name : P8

Source/Organism : Ceropin A-African clawed frog

Linear/Cyclic : Linear

Chirality : L

Sequence Information

Sequence : KWKKFLKIGIGKFLHLAKKF

Peptide length: 20

C-terminal modification: Linear

N-terminal modification : Amidation

Non-natural peptide information: None

Activity Information

Assay type : MTT/MTS assay

Assay time : 72h

Activity : IC50 : 2.6 µM

Cell line : NCI-H69

Cancer type : Lung cancer

Other activity : Hemolytic activity

Physicochemical Properties

Amino acid composition bar chart :

Molecular mass : 2431.0605 Dalton

Aliphatic index : 1.025

Instability index : -7.48

Hydrophobicity (GRAVY) : -0.08

Isoelectric point : 10.778

Charge (pH 7) : 6.8403

Aromaticity : 0.2

Molar extinction coefficient (cysteine, cystine): (5500, 5500)

Hydrophobic/hydrophilic ratio : 1.5

hydrophobic moment : -0.759

Missing amino acid : C,R,Q,T,P,M,E,S,D,Y,N,V

Most occurring amino acid : K

Most occurring amino acid frequency : 7

Least occurring amino acid : W

Least occurring amino acid frequency : 1

Structural Information

3D structure :

Secondary structure fraction (Helix, Turn, Sheet): (0.5, 0.1, 0.4)

SMILES Notation: CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O

Secondary Structure :

Method Prediction
GOR HHHHHHHHHHHHHHHHHHHH
Chou-Fasman (CF) HHHHEEEEEEHHHHHHHCCC
Neural Network (NN) HHHHHHHHHHHHHHHHHHHH
Joint/Consensus HHHHHHHHHHHHHHHHHHHH

Molecular Descriptors and ADMET Properties

Molecular Descriptors: Click here to download

ADMET Properties: Click here to download

Cross Referencing databases

Pubmed Id : 9352466

Uniprot : Not available

PDB : Not available

CancerPPD : Click here

ApIAPDB : Not available

CancerPPD2 ID : Not available

Reference

1 : Shin SY, et al. Structure-antitumor and hemolytic activity relationships of synthetic peptides derived from cecropin A-magainin 2 and cecropin A-melittin hybrid peptides. J Pept Res. 1997; 50:279-85. doi: 10.1111/j.1399-3011.1997.tb01469.x

Literature

Paper title : Structure-antitumor and hemolytic activity relationships of synthetic peptides derived from cecropin A-magainin 2 and cecropin A-melittin hybrid peptides.

Doi : https://doi.org/10.1111/j.1399-3011.1997.tb01469.x

Abstract : The hybrid peptide (CA-ME) derived from cecropin A(1-8) and melittin (1-12) has potent antibacterial and antimalarial activities. Because the N-terminal sequence 1-12 of magainin 2 is similar to melittin(1-12), CA-MA with CA(1-8) and MA(1-12) and their analogues were designed and synthesized. Antitumor activities of these peptides were evaluated using three small cell lung cancer cell lines. Greater antitumor activity was observed when the residues 16, 18 and 19 of the peptide were hydrophobic (Leu or Val), basic (Lys) and basic (Lys), respectively. The IC50 values of the peptides with the residues were 2 to 4 microM. Residue 12 was related to hemolytic activity rather than antitumor activity. Increase in amphipathicity of P4 enhanced hemolytic activity without significant change in antitumor activity. The alpha-helicity of the peptides in a 30 mM sodium dodecyl sulfate solution was more closely correlated to hemolytic activity than antitumor activity.